27 min listen
Episode 92: Doxorubicin: The Infamous Red Devil
Episode 92: Doxorubicin: The Infamous Red Devil
ratings:
Length:
20 minutes
Released:
Feb 28, 2020
Format:
Podcast episode
Description
ONS member Christine Rimkus, RN, MSN, AOCN®, clinical nurse specialist for the Siteman Cancer Center at Washington University in St. Louis, MO, and member of the St. Louis ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss doxorubicin—otherwise known as the red devil—chemotherapy administration, what nurses need to know about vesicants in practice, and how to support and advocate for patients receiving doxorubicin treatment. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons: By Attribution 3.0 Episode Notes Check out these resources from today’s episode: The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities. Outpatient Oncology Drug Series: Doxorubicin Is the Infamous Red Devil The Case of the Vexing Vesicant Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice Understanding and Managing Oncologic Emergencies: A Resource for Nurses (Third Edition)
Released:
Feb 28, 2020
Format:
Podcast episode
Titles in the series (100)
Episode 2: Financial Toxicity in Patients With Cancer: Teresa Hagan Thomas, PhD, RN, assistant professor from the University of Pittsburgh School of Nursing sits down with ONS Staff Writer, Chris Pirschel to discuss financial toxicity and its impact on patients with cancer. For more oncology nursing... by The Oncology Nursing Podcast